## Enzyme Aging in Organophosphate Poisoning ### Definition and Mechanism **Key Point:** Aging is the loss of an alkyl group from the phosphorylated acetylcholinesterase complex, rendering the enzyme-inhibitor bond irreversible and resistant to pralidoxime (2-PAM) reactivation. ### Timeline and Biochemistry ```mermaid flowchart TD A[Organophosphate + AChE]:::outcome --> B[Phosphorylated AChE<br/>Reversible complex]:::outcome B --> C{Time passes}:::decision C -->|Minutes to hours<br/>Pralidoxime effective| D[2-PAM can reactivate enzyme]:::action C -->|Hours to days<br/>Aging occurs| E[Loss of alkyl group<br/>Aged complex formed]:::outcome E --> F[Irreversible inhibition<br/>Pralidoxime ineffective]:::urgent ``` ### Key Distinctions | Phase | Process | Pralidoxime Efficacy | Duration | |-------|---------|----------------------|-----------| | **Pre-aging** | Phosphorylated AChE intact (2 alkyl groups) | **Effective** | Minutes to hours | | **Aging** | Loss of one alkyl group via dealkylation | **Ineffective** | Begins within hours; varies by OP | | **Aged complex** | Monoalkyl phosphorylated AChE | **Not reversible** | Permanent until new AChE synthesized | ### Clinical Significance **High-Yield:** Aging is why pralidoxime must be given **early** (ideally within 24–48 hours, but efficacy decreases with time). Once aging occurs, only supportive care and atropine remain effective. **Mnemonic:** **AGING = Alkyl Group Is Negated** — one alkyl group is lost, making the bond irreversible. **Clinical Pearl:** Different organophosphates age at different rates. For example, parathion ages slowly, while some nerve agents age within minutes. This determines the window for pralidoxime therapy. [cite:Park 26e Ch 14; Reddy & Rao Forensic Medicine & Toxicology Ch 18] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.